Annual Revenue
$8.27 M
-$1.98 M-19.30%
December 31, 2023
Summary
- As of February 7, 2025, MEDS annual revenue is $8.27 million, with the most recent change of -$1.98 million (-19.30%) on December 31, 2023.
- During the last 3 years, MEDS annual revenue has fallen by -$8.85 million (-51.69%).
Performance
MEDS Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Revenue
$64.86 K
+$46.16 K+246.85%
September 30, 2024
Summary
- As of February 7, 2025, MEDS quarterly revenue is $64.86 thousand, with the most recent change of +$46.16 thousand (+246.85%) on September 30, 2024.
Performance
MEDS Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Related metrics
TTM Revenue
$2.44 M
-$1.99 M-45.00%
September 30, 2024
Summary
- As of February 7, 2025, MEDS TTM revenue is $2.44 million, with the most recent change of -$1.99 million (-45.00%) on September 30, 2024.
Performance
MEDS TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
MEDS Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -19.3% | - | - |
| 3 y3 years | -51.7% | -97.5% | -74.3% |
| 5 y5 years | +115.9% | -97.2% | -67.2% |
MEDS Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -19.3% | at low | -98.0% | -71.2% | -78.7% | at low |
| 5 y | 5-year | -51.7% | -10.1% | -99.0% | -71.2% | -86.4% | at low |
| alltime | all time | -51.7% | -88.4% | -99.0% | -1007.6% | -86.4% | -89.5% |
TRxADE HEALTH Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $64.86 K(+246.9%) | $2.44 M(-45.0%) |
| Jun 2024 | - | $18.70 K(-99.2%) | $4.43 M(-16.0%) |
| Dec 2023 | $8.27 M(-19.3%) | $2.35 M(+14.3%) | $5.27 M(+1.9%) |
| Sep 2023 | - | $2.06 M(+461.5%) | $5.17 M(+0.0%) |
| Jun 2023 | - | $366.50 K(-25.7%) | $5.17 M(-36.0%) |
| Mar 2023 | - | $493.30 K(-78.1%) | $8.08 M(-25.4%) |
| Dec 2022 | $10.25 M(+3.6%) | $2.26 M(+9.8%) | $10.83 M(-1.2%) |
| Sep 2022 | - | $2.06 M(-37.3%) | $10.96 M(-4.3%) |
| Jun 2022 | - | $3.28 M(+1.2%) | $11.46 M(+13.7%) |
| Mar 2022 | - | $3.24 M(+35.7%) | $10.08 M(+1.9%) |
| Dec 2021 | $9.89 M(-42.2%) | $2.39 M(-6.4%) | $9.89 M(+4.1%) |
| Sep 2021 | - | $2.55 M(+34.3%) | $9.50 M(-28.5%) |
| Jun 2021 | - | $1.90 M(-37.8%) | $13.28 M(-26.1%) |
| Mar 2021 | - | $3.05 M(+53.1%) | $17.97 M(+5.0%) |
| Dec 2020 | $17.12 M(+130.3%) | $1.99 M(-68.5%) | $17.12 M(+1.8%) |
| Sep 2020 | - | $6.33 M(-3.9%) | $16.82 M(+31.4%) |
| Jun 2020 | - | $6.59 M(+199.2%) | $12.80 M(+57.5%) |
| Mar 2020 | - | $2.20 M(+29.9%) | $8.13 M(+9.3%) |
| Dec 2019 | $7.44 M(+94.1%) | $1.70 M(-26.6%) | $7.44 M(+5.7%) |
| Sep 2019 | - | $2.31 M(+20.6%) | $7.03 M(+26.3%) |
| Jun 2019 | - | $1.92 M(+26.7%) | $5.57 M(+24.0%) |
| Mar 2019 | - | $1.51 M(+16.9%) | $4.49 M(+17.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | $3.83 M(+30.7%) | $1.29 M(+52.6%) | $3.83 M(+15.1%) |
| Sep 2018 | - | $847.50 K(+1.2%) | $3.33 M(+3.5%) |
| Jun 2018 | - | $837.70 K(-1.8%) | $3.22 M(+4.3%) |
| Mar 2018 | - | $852.90 K(+8.0%) | $3.08 M(+3.6%) |
| Dec 2017 | $2.93 M(+18.1%) | $789.70 K(+7.3%) | $2.98 M(+5.4%) |
| Sep 2017 | - | $735.90 K(+4.4%) | $2.82 M(+4.6%) |
| Jun 2017 | - | $704.70 K(-5.5%) | $2.70 M(+4.5%) |
| Mar 2017 | - | $745.90 K(+16.9%) | $2.58 M(+4.1%) |
| Dec 2016 | $2.48 M(-14.8%) | $638.00 K(+4.5%) | $2.48 M(+97.7%) |
| Sep 2016 | - | $610.80 K(+3.8%) | $1.26 M(-45.0%) |
| Jun 2016 | - | $588.50 K(-8.7%) | $2.28 M(-20.2%) |
| Mar 2016 | - | $644.50 K(-209.5%) | $2.86 M(-1.8%) |
| Dec 2015 | $2.91 M(+94.7%) | -$588.70 K(-135.9%) | $2.91 M(-28.8%) |
| Sep 2015 | - | $1.64 M(+40.3%) | $4.09 M(+44.7%) |
| Jun 2015 | - | $1.17 M(+67.7%) | $2.83 M(+45.1%) |
| Mar 2015 | - | $696.10 K(+17.7%) | $1.95 M(+30.2%) |
| Dec 2014 | $1.50 M(+56.5%) | $591.60 K(+58.7%) | $1.50 M(+35.2%) |
| Sep 2014 | - | $372.70 K(+29.5%) | $1.11 M(+4.7%) |
| Jun 2014 | - | $287.70 K(+17.8%) | $1.06 M(+3.2%) |
| Mar 2014 | - | $244.20 K(+21.1%) | $1.02 M(+31.3%) |
| Dec 2013 | $955.90 K | $201.70 K(-37.6%) | $779.70 K(+34.9%) |
| Sep 2013 | - | $323.40 K(+27.0%) | $578.00 K(+127.0%) |
| Jun 2013 | - | $254.60 K | $254.60 K |
FAQ
- What is TRxADE HEALTH annual revenue?
- What is the all time high annual revenue for TRxADE HEALTH?
- What is TRxADE HEALTH annual revenue year-on-year change?
- What is TRxADE HEALTH quarterly revenue?
- What is the all time high quarterly revenue for TRxADE HEALTH?
- What is TRxADE HEALTH TTM revenue?
- What is the all time high TTM revenue for TRxADE HEALTH?
What is TRxADE HEALTH annual revenue?
The current annual revenue of MEDS is $8.27 M
What is the all time high annual revenue for TRxADE HEALTH?
TRxADE HEALTH all-time high annual revenue is $17.12 M
What is TRxADE HEALTH annual revenue year-on-year change?
Over the past year, MEDS annual revenue has changed by -$1.98 M (-19.30%)
What is TRxADE HEALTH quarterly revenue?
The current quarterly revenue of MEDS is $64.86 K
What is the all time high quarterly revenue for TRxADE HEALTH?
TRxADE HEALTH all-time high quarterly revenue is $6.59 M
What is TRxADE HEALTH TTM revenue?
The current TTM revenue of MEDS is $2.44 M
What is the all time high TTM revenue for TRxADE HEALTH?
TRxADE HEALTH all-time high TTM revenue is $17.97 M